For BC, ATP6V1C2 is only overexpressed or gnomically amplified in 7% of cases, and its overexpression or genomic amplification did not significantly correspond to effects on patients’ survival (McConnell et al., 2017). The gene discussed is ATP6V1C2; the disease is breast cancer.